153 related articles for article (PubMed ID: 19657189)
1. Anticancer activity and differentially expressed genes in head and neck cancer cells treated with a novel cyclin-dependent kinase inhibitor.
Shin HC; Song DW; Baek WK; Lee SR; Kwon TK; Lee J; Park SH; Jang BC; Park JW
Chemotherapy; 2009; 55(5):353-62. PubMed ID: 19657189
[TBL] [Abstract][Full Text] [Related]
2. BAI, a novel cyclin-dependent kinase inhibitor induces apoptosis in A549 cells through activation of caspases and inactivation of Akt.
Kim S; Lee J; Jang BC; Kwon TK; Park JW
J Cell Biochem; 2013 Feb; 114(2):282-93. PubMed ID: 22887215
[TBL] [Abstract][Full Text] [Related]
3. Mechanism of apicidin-induced cell cycle arrest and apoptosis in Ishikawa human endometrial cancer cells.
Ahn MY; Lee J; Na YJ; Choi WS; Lee BM; Kang KW; Kim HS
Chem Biol Interact; 2009 May; 179(2-3):169-77. PubMed ID: 19070610
[TBL] [Abstract][Full Text] [Related]
4. BAI, a novel Cdk inhibitor, enhances farnesyltransferase inhibitor LB42708-mediated apoptosis in renal carcinoma cells through the downregulation of Bcl-2 and c-FLIP (L).
Jang JH; Cho YC; Kim KH; Lee KS; Lee J; Kim DE; Park JS; Jang BC; Kim S; Kwon TK; Park JW
Int J Oncol; 2014 Oct; 45(4):1680-90. PubMed ID: 24993441
[TBL] [Abstract][Full Text] [Related]
5. Novel indoloquinoline derivative, IQDMA, induces G(2)/M phase arrest and apoptosis in A549 cells through JNK/p38 MAPK signaling activation.
Su JC; Lin KL; Chien CM; Lu CM; Chen YL; Chang LS; Lin SR
Life Sci; 2009 Sep; 85(13-14):505-16. PubMed ID: 19699753
[TBL] [Abstract][Full Text] [Related]
6. Flavopiridol, an inhibitor of cyclin-dependent kinases, induces growth inhibition and apoptosis in bladder cancer cells in vitro and in vivo.
Wirger A; Perabo FG; Burgemeister S; Haase L; Schmidt DH; Doehn C; Mueller SC; Jocham D
Anticancer Res; 2005; 25(6B):4341-7. PubMed ID: 16309238
[TBL] [Abstract][Full Text] [Related]
7. Protein kinase C is involved in arsenic trioxide-induced apoptosis and inhibition of proliferation in human bladder cancer cells.
Wang Y; An R; Dong X; Pan S; Duan G; Sun X
Urol Int; 2009; 82(2):214-21. PubMed ID: 19322013
[TBL] [Abstract][Full Text] [Related]
8. Inhibition of neuronal apoptosis by the cyclin-dependent kinase inhibitor GW8510: identification of 3' substituted indolones as a scaffold for the development of neuroprotective drugs.
Johnson K; Liu L; Majdzadeh N; Chavez C; Chin PC; Morrison B; Wang L; Park J; Chugh P; Chen HM; D'Mello SR
J Neurochem; 2005 May; 93(3):538-48. PubMed ID: 15836613
[TBL] [Abstract][Full Text] [Related]
9. Inhibition of cell-cycle progression in HeLa cells by HY52, a novel cyclin-dependent kinase inhibitor isolated from Bauhinia forficata.
Lim H; Kim MK; Lim Y; Cho YH; Lee CH
Cancer Lett; 2006 Feb; 233(1):89-97. PubMed ID: 16473670
[TBL] [Abstract][Full Text] [Related]
10. SNS-032 is a potent and selective CDK 2, 7 and 9 inhibitor that drives target modulation in patient samples.
Conroy A; Stockett DE; Walker D; Arkin MR; Hoch U; Fox JA; Hawtin RE
Cancer Chemother Pharmacol; 2009 Sep; 64(4):723-32. PubMed ID: 19169685
[TBL] [Abstract][Full Text] [Related]
11. Effects of emodin on the gene expression profiling of human breast carcinoma cells.
Huang Z; Chen G; Shi P
Cancer Detect Prev; 2009; 32(4):286-91. PubMed ID: 19185431
[TBL] [Abstract][Full Text] [Related]
12. Growth inhibition and induction of apoptosis by 2-methoxyestradiol in rat osteosarcoma and malignant fibrous histiocytoma cell lines.
Fujii H; Honoki K; Tsujiuchi T; Kido A; Yoshitani K; Takakura Y
In Vivo; 2008; 22(1):21-5. PubMed ID: 18396777
[TBL] [Abstract][Full Text] [Related]
13. ATP-noncompetitive inhibitors of CDK-cyclin complexes.
Orzáez M; Gortat A; Mondragón L; Bachs O; Pérez-Payá E
ChemMedChem; 2009 Jan; 4(1):19-24. PubMed ID: 19039815
[TBL] [Abstract][Full Text] [Related]
14. The multi-target drug BAI induces apoptosis in various human cancer cells through modulation of Bcl-xL protein.
Kim S; Kim DE; Kwon TK; Lee J; Park JW
Int J Oncol; 2016 Dec; 49(6):2620-2628. PubMed ID: 27840907
[TBL] [Abstract][Full Text] [Related]
15. XRP6258-induced gene expression patterns in head and neck cancer carcinoma.
Yoo GH; Kafri Z; Ensley JF; Lonardo F; Kim H; Folbe AJ; Won J; Stevens T; Lin HS
Laryngoscope; 2010 Jun; 120(6):1114-9. PubMed ID: 20513026
[TBL] [Abstract][Full Text] [Related]
16. Effects of carbonyl cyanide p-(trifluoromethoxy) phenylhydrazone on the growth inhibition in human pulmonary adenocarcinoma Calu-6 cells.
Han YH; Moon HJ; You BR; Kim SZ; Kim SH; Park WH
Toxicology; 2009 Nov; 265(3):101-7. PubMed ID: 19819288
[TBL] [Abstract][Full Text] [Related]
17. Molecular mechanisms underlying N1, N11-diethylnorspermine-induced apoptosis in a human breast cancer cell line.
Holst CM; Staaf J; Jönsson G; Hegardt C; Oredsson SM
Anticancer Drugs; 2008 Oct; 19(9):871-83. PubMed ID: 18766001
[TBL] [Abstract][Full Text] [Related]
18. Inhibitive effect of 3-bromopyruvic acid on human breast cancer MCF-7 cells involves cell cycle arrest and apoptotic induction.
Liu XH; Zheng XF; Wang YL
Chin Med J (Engl); 2009 Jul; 122(14):1681-5. PubMed ID: 19719971
[TBL] [Abstract][Full Text] [Related]
19. A novel histone deacetylase inhibitor, CG0006, induces cell death through both extrinsic and intrinsic apoptotic pathways.
Hwang JJ; Kim YS; Kim MJ; Jang S; Lee JH; Choi J; Ro S; Hyun YL; Lee JS; Kim CS
Anticancer Drugs; 2009 Oct; 20(9):815-21. PubMed ID: 19644355
[TBL] [Abstract][Full Text] [Related]
20. Cyclins and related kinases in cancer cells.
Malumbres M
J BUON; 2007 Sep; 12 Suppl 1():S45-52. PubMed ID: 17935277
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
